- ￥2588
- abinscience
- France
- HY465036
- 2026年03月03日
- Research Grade Biosimilar
- Human
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human
- 亚型：
IgG
- 形态：
Liquid
- 保存条件：
0.01M PBS,pH7.4.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
HY465036
- 级别：
科研级别
- 库存：
999
- 供应商：
abinscience
- 宿主：
Human
- 应用范围：
Research Grade Biosimilar
- 浓度：
1 mg/ml
- 靶点：
HLA-DR antigens-associated invariant chain, HLA class II histocompatibility antigen gamma chain, CD74, CLIP, Ia antigen-associated invariant chain, DHLAG, Ii
- 抗体英文名：
Research Grade Anti-Human HLA-DR (IMMU-114)
- 抗体名：
Research Grade Anti-Human HLA-DR (IMMU-114)
- 规格：
100ug
| Product name | Research Grade Anti-Human HLA-DR (IMMU-114) |
|---|---|
| Catalog No. | HY465036 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Endotoxin level | Please contact the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | P04233 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -1594°C. |
| Alternative Names | IMMU-114,IMMU114,IMMU114 |
| Species | \ |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
Abinscience, founded in 2023 and located in the innovation technology center in Strasbourg, France, is the core research reagent brand of ProteoGenix. Focusing on the development and production of life science research reagents, Abinscience takes "Empowering Bioscience Discovery" as its vision, and is committed to providing high-quality and innovative biological reagent products and technical solutions for global researchers.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Guide to Cell Proliferation and Apoptosis Methods
Anti-Bcl-2 oncoprotein, human 44 Anti-p53 Protein, mutant 46 Anti-p53 Protein pan 46 Anti-p53 pan
8.30 华科最新研究：免疫机制参与心肌梗死后缺血性心力衰竭
① 华中科技大学最新研究：免疫机制参与心肌梗死后缺血性心力衰竭华中科技大学同济医学院附属协和医院心血管内科程翔教授研究团队发现了缺血性心力衰竭患者心脏局部 T 淋巴细胞免疫组库特征及免疫功能表型，在缺血性心力衰竭的免疫发病机制领域取得重要进展。这一研究团队发现在梗死后心力衰竭患者的心脏局部存在显著的 T 细胞应答；心脏局部的 T 细胞具有克隆扩增和组织特异性的表型，分泌促纤维化及促凋亡因子参与不良心室重构，且能再次进入外周循环；CLEC9A+树突状细胞及 HLA-DR+巨噬细胞参与心脏局部 T
Barry F, Boynton R, Murphy M, Zaia J. The SH-3 and SH-4 Antibodies Recognize Distinct Epitopes on CD73 from Human Mesenchymal Stem Cells. Biochemical and Biophysical Research Communications 2001;289:519-524. SH
技术资料暂无技术资料 索取技术资料
